Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:39 pm Sale | 13G | ACURX PHARMACEUTICALS INC ACXP | ARMISTICE CAPITAL LLC | 723,104 4.99% | -156,896 (-17.83%) | View |
| 2023-02-14 11:59 am Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ARMISTICE CAPITAL LLC | 2,997,111 9.99% | 2,997,111 (New Position) | View |
| 2023-02-14 11:52 am Purchase | 13G | ACURX PHARMACEUTICALS INC ACXP | ARMISTICE CAPITAL LLC | 880,000 7.59% | 880,000 (New Position) | View |
| 2021-07-06 4:21 pm Purchase | 13D | ACURX PHARMACEUTICALS INC ACXP | LUCI DAVID P | 1,351,106 13.2% | 1,351,106 (New Position) | View |
| 2021-07-06 4:20 pm Purchase | 13D | ACURX PHARMACEUTICALS INC ACXP | DELUCCIA ROBERT J | 1,327,774 13% | 1,327,774 (New Position) | View |